Anti-Human HGF Recombinant Antibody(Rilotumumab)

Name: Anti-Human HGF Recombinant Antibody(Rilotumumab)
Brand: KMD Bioscience
SKU: YR1200

YR1200

科研级 Rilotumumab ( 利妥木单抗 ), Anti-HGF Recombinant Antibody, Research Grade Rilotumumab

DATASHEET MSDS

Product Description

Alias	科研级 Rilotumumab ( 利妥木单抗 ), Anti-HGF Recombinant Antibody, Research Grade Rilotumumab
Catalog Number	YR1200
Molecular Name	Rilotumumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG2 Kappa
Formulation	PBS, pH7.5
Background	Rilotumumab (previously AMG102) is a human monoclonal antibody designed for the treatment of solid tumors. Rilotumumab was in development by Amgen, Inc. until in November 2014, when Amgen announced it had halted all clinical trials of the compound in advanced gastric cancer (including two Phase III studies) after one of the trials found an increase in the number of deaths in those who were taking rilotumumab and chemotherapy when compared to those who were only administered chemotherapy.
CAS Number	872514-65-3
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Target	HGF[Homo sapiens]

Login